Header cover image

German Pharmaceuticals & Biotech Undiscovered Growth Opportunities

UPDATED May 18, 2022

The market has not yet priced in the high-growth prospects for these companies, featuring low PEG ratio (less than 0.5), high future growth outlook and good value on the Snowflake.

5 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
UQ1uniQure€13.16-1.8%-50.6%€660.1m€49.95PS2xE22.5%n/a
UQ1uniQure€13.50-4.5%-50.0%€660.1m€51.22PS2xE22.5%n/a
84CClene€2.04-13.6%-72.2%€139.8m€13.85PS8.4xE72.5%n/a
X0M1XOMA€16.40-1.8%-33.9%€203.0m€57.68PS16.9xE58.1%n/a
VB0Viva Biotech Holdings€0.264.0%-64.6%€4.3bn/aPS13xE36.0%0%
Page 1 of 1